 | • レポートコード：MRC2Q12-16758 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、画像診断臨床試験のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 画像診断臨床試験のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 画像診断臨床試験の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 画像診断臨床試験のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの画像診断臨床試験の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の画像診断臨床試験の売上および2028年までの予測に焦点を当てています。 画像診断臨床試験のグローバル主要企業には、ICON、Parexel、BioTelemetry、ERT、McLaren、Bioclinica、ProScan Imaging、Radiant Sage、Micron, Inc.、Imaging Endpoints、Intrinsic Imaging、Median Technologiesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 画像診断臨床試験市場は、タイプとアプリケーションによって区分されます。世界の画像診断臨床試験市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 放射線画像診断、非放射線画像診断 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 画像診断臨床試験製品概要 - タイプ別市場（放射線画像診断、非放射線画像診断） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の画像診断臨床試験販売量予測2017-2028 - 世界の画像診断臨床試験売上予測2017-2028 - 画像診断臨床試験の地域別販売量 - 画像診断臨床試験の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別画像診断臨床試験販売量 - 主要メーカー別画像診断臨床試験売上 - 主要メーカー別画像診断臨床試験価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（放射線画像診断、非放射線画像診断） - 画像診断臨床試験のタイプ別販売量 - 画像診断臨床試験のタイプ別売上 - 画像診断臨床試験のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 画像診断臨床試験のアプリケーション別販売量 - 画像診断臨床試験のアプリケーション別売上 - 画像診断臨床試験のアプリケーション別価格 ・北米市場 - 北米の画像診断臨床試験市場規模（タイプ別、アプリケーション別） - 主要国別の画像診断臨床試験市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの画像診断臨床試験市場規模（タイプ別、アプリケーション別） - 主要国別の画像診断臨床試験市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の画像診断臨床試験市場規模（タイプ別、アプリケーション別） - 主要国別の画像診断臨床試験市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の画像診断臨床試験市場規模（タイプ別、アプリケーション別） - 主要国別の画像診断臨床試験市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの画像診断臨床試験市場規模（タイプ別、アプリケーション別） - 主要国別の画像診断臨床試験市場規模（トルコ、サウジアラビア） ・企業情報 ICON、Parexel、BioTelemetry、ERT、McLaren、Bioclinica、ProScan Imaging、Radiant Sage、Micron, Inc.、Imaging Endpoints、Intrinsic Imaging、Median Technologies ・産業チェーン及び販売チャネル分析 - 画像診断臨床試験の産業チェーン分析 - 画像診断臨床試験の原材料 - 画像診断臨床試験の生産プロセス - 画像診断臨床試験の販売及びマーケティング - 画像診断臨床試験の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 画像診断臨床試験の産業動向 - 画像診断臨床試験のマーケットドライバー - 画像診断臨床試験の課題 - 画像診断臨床試験の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Diagnostic Imaging Clinical Trials estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Diagnostic Imaging Clinical Trials is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Diagnostic Imaging Clinical Trials is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Diagnostic Imaging Clinical Trials is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Diagnostic Imaging Clinical Trials include ICON, Parexel, BioTelemetry, ERT, McLaren, Bioclinica, ProScan Imaging, Radiant Sage and Micron, Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Diagnostic Imaging Clinical Trials companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Diagnostic Imaging Clinical Trials market. Further, it explains the major drivers and regional dynamics of the global Diagnostic Imaging Clinical Trials market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
ICON
Parexel
BioTelemetry
ERT
McLaren
Bioclinica
ProScan Imaging
Radiant Sage
Micron, Inc.
Imaging Endpoints
Intrinsic Imaging
Median Technologies
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Diagnostic Imaging Clinical Trials Segment by Type
Radiological Imaging Diagnosis
Non-radioactive Imaging Diagnosis
Diagnostic Imaging Clinical Trials Segment by Application
Hospital
Clinic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Diagnostic Imaging Clinical Trials market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Diagnostic Imaging Clinical Trials market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Diagnostic Imaging Clinical Trials, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diagnostic Imaging Clinical Trials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diagnostic Imaging Clinical Trials revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Diagnostic Imaging Clinical Trials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Diagnostic Imaging Clinical Trials revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ICON, Parexel, BioTelemetry, ERT, McLaren, Bioclinica, ProScan Imaging, Radiant Sage and Micron, Inc., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Diagnostic Imaging Clinical Trials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Imaging Clinical Trials companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Imaging Clinical Trials revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radiological Imaging Diagnosis
1.2.3 Non-radioactive Imaging Diagnosis
1.3 Market by Application
1.3.1 Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Imaging Clinical Trials Market Perspective (2017-2028)
2.2 Diagnostic Imaging Clinical Trials Growth Trends by Region
2.2.1 Diagnostic Imaging Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diagnostic Imaging Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 Diagnostic Imaging Clinical Trials Market Dynamics
2.3.1 Diagnostic Imaging Clinical Trials Industry Trends
2.3.2 Diagnostic Imaging Clinical Trials Market Drivers
2.3.3 Diagnostic Imaging Clinical Trials Market Challenges
2.3.4 Diagnostic Imaging Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue
3.1.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global Diagnostic Imaging Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global Diagnostic Imaging Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Imaging Clinical Trials Revenue
3.4 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio
3.4.1 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Clinical Trials Revenue in 2021
3.5 Diagnostic Imaging Clinical Trials Key Players Head office and Area Served
3.6 Key Players Diagnostic Imaging Clinical Trials Product Solution and Service
3.7 Date of Enter into Diagnostic Imaging Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Imaging Clinical Trials Breakdown Data by Type
4.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Type (2017-2022)
4.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2023-2028)
5 Diagnostic Imaging Clinical Trials Breakdown Data by Application
5.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Diagnostic Imaging Clinical Trials Market Size (2017-2028)
6.2 North America Diagnostic Imaging Clinical Trials Market Size by Type
6.2.1 North America Diagnostic Imaging Clinical Trials Market Size by Type (2017-2022)
6.2.2 North America Diagnostic Imaging Clinical Trials Market Size by Type (2023-2028)
6.2.3 North America Diagnostic Imaging Clinical Trials Market Share by Type (2017-2028)
6.3 North America Diagnostic Imaging Clinical Trials Market Size by Application
6.3.1 North America Diagnostic Imaging Clinical Trials Market Size by Application (2017-2022)
6.3.2 North America Diagnostic Imaging Clinical Trials Market Size by Application (2023-2028)
6.3.3 North America Diagnostic Imaging Clinical Trials Market Share by Application (2017-2028)
6.4 North America Diagnostic Imaging Clinical Trials Market Size by Country
6.4.1 North America Diagnostic Imaging Clinical Trials Market Size by Country (2017-2022)
6.4.2 North America Diagnostic Imaging Clinical Trials Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diagnostic Imaging Clinical Trials Market Size (2017-2028)
7.2 Europe Diagnostic Imaging Clinical Trials Market Size by Type
7.2.1 Europe Diagnostic Imaging Clinical Trials Market Size by Type (2017-2022)
7.2.2 Europe Diagnostic Imaging Clinical Trials Market Size by Type (2023-2028)
7.2.3 Europe Diagnostic Imaging Clinical Trials Market Share by Type (2017-2028)
7.3 Europe Diagnostic Imaging Clinical Trials Market Size by Application
7.3.1 Europe Diagnostic Imaging Clinical Trials Market Size by Application (2017-2022)
7.3.2 Europe Diagnostic Imaging Clinical Trials Market Size by Application (2023-2028)
7.3.3 Europe Diagnostic Imaging Clinical Trials Market Share by Application (2017-2028)
7.4 Europe Diagnostic Imaging Clinical Trials Market Size by Country
7.4.1 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2017-2022)
7.4.2 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Type
8.2.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Share by Type (2017-2028)
8.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Application
8.3.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Share by Application (2017-2028)
8.4 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region
8.4.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diagnostic Imaging Clinical Trials Market Size (2017-2028)
9.2 Latin America Diagnostic Imaging Clinical Trials Market Size by Type
9.2.1 Latin America Diagnostic Imaging Clinical Trials Market Size by Type (2017-2022)
9.2.2 Latin America Diagnostic Imaging Clinical Trials Market Size by Type (2023-2028)
9.2.3 Latin America Diagnostic Imaging Clinical Trials Market Share by Type (2017-2028)
9.3 Latin America Diagnostic Imaging Clinical Trials Market Size by Application
9.3.1 Latin America Diagnostic Imaging Clinical Trials Market Size by Application (2017-2022)
9.3.2 Latin America Diagnostic Imaging Clinical Trials Market Size by Application (2023-2028)
9.3.3 Latin America Diagnostic Imaging Clinical Trials Market Share by Application (2017-2028)
9.4 Latin America Diagnostic Imaging Clinical Trials Market Size by Country
9.4.1 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2017-2022)
9.4.2 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Type
10.2.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Share by Type (2017-2028)
10.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Application
10.3.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Share by Application (2017-2028)
10.4 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country
10.4.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Diagnostic Imaging Clinical Trials Introduction
11.1.4 ICON Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.1.5 ICON Recent Developments
11.2 Parexel
11.2.1 Parexel Company Details
11.2.2 Parexel Business Overview
11.2.3 Parexel Diagnostic Imaging Clinical Trials Introduction
11.2.4 Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.2.5 Parexel Recent Developments
11.3 BioTelemetry
11.3.1 BioTelemetry Company Details
11.3.2 BioTelemetry Business Overview
11.3.3 BioTelemetry Diagnostic Imaging Clinical Trials Introduction
11.3.4 BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.3.5 BioTelemetry Recent Developments
11.4 ERT
11.4.1 ERT Company Details
11.4.2 ERT Business Overview
11.4.3 ERT Diagnostic Imaging Clinical Trials Introduction
11.4.4 ERT Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.4.5 ERT Recent Developments
11.5 McLaren
11.5.1 McLaren Company Details
11.5.2 McLaren Business Overview
11.5.3 McLaren Diagnostic Imaging Clinical Trials Introduction
11.5.4 McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.5.5 McLaren Recent Developments
11.6 Bioclinica
11.6.1 Bioclinica Company Details
11.6.2 Bioclinica Business Overview
11.6.3 Bioclinica Diagnostic Imaging Clinical Trials Introduction
11.6.4 Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.6.5 Bioclinica Recent Developments
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Details
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Diagnostic Imaging Clinical Trials Introduction
11.7.4 ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.7.5 ProScan Imaging Recent Developments
11.8 Radiant Sage
11.8.1 Radiant Sage Company Details
11.8.2 Radiant Sage Business Overview
11.8.3 Radiant Sage Diagnostic Imaging Clinical Trials Introduction
11.8.4 Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.8.5 Radiant Sage Recent Developments
11.9 Micron, Inc.
11.9.1 Micron, Inc. Company Details
11.9.2 Micron, Inc. Business Overview
11.9.3 Micron, Inc. Diagnostic Imaging Clinical Trials Introduction
11.9.4 Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.9.5 Micron, Inc. Recent Developments
11.10 Imaging Endpoints
11.10.1 Imaging Endpoints Company Details
11.10.2 Imaging Endpoints Business Overview
11.10.3 Imaging Endpoints Diagnostic Imaging Clinical Trials Introduction
11.10.4 Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.10.5 Imaging Endpoints Recent Developments
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Details
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Diagnostic Imaging Clinical Trials Introduction
11.11.4 Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.11.5 Intrinsic Imaging Recent Developments
11.12 Median Technologies
11.12.1 Median Technologies Company Details
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Diagnostic Imaging Clinical Trials Introduction
11.12.4 Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2017-2022)
11.12.5 Median Technologies Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer